Frost & Sullivan's Award underlined Mindray's Innovative practice
Mindray, based in Shenzhen, China, was founded in 1991. The company's success has been built on innovation in the past 20 years. Started as a supplier of patient monitors, the company gradually expanded its business to in-vitro diagnostics, ultrasound, radiographic equipment and ICU/OR overall solution etc. In 2010, the company received China Food and Drug Administration approval to launch its BeneHeart D6 biphasic defibrillator, which made Mindray the first domestic medical equipment enterprise to manufacture such product. Compared with some foreign brand machines in the market, Mindray's BeneHeart D6 biphasic defibrillator is reliable, user friendly, and equipped with innovative data transmission systems and multi-parameter monitoring functions.
Report from Frost & Sullivan indicates, besides its competitive technologies, Mindray also excels in both product line planning and marketing methods innovation. Mindray's growth strategies have resulted in outstanding sales performance in both urban and rural health care markets in China, as well as countries overseas.
Open WeChat and Scan the QR code .Get the Webpage and Share on Moments.
Mindray launches the new BeneHeart C Series AED to enhance resuscitation confidence2019-09-12
Mindray Showcases Latest IVD Innovations at EuroMedlab 20192019-06-28
Mindray at CMEF 2019: A Journey of Global Healthcare2019-05-20
Mindray introduces new high-end HyLED X Series surgical lights to protect the eyes of surgeons2019-04-30
The New MWAN Wi-Fi Technology Leads Safer Ambulatory Patient Monitoring2019-04-09